Trupanion (NASDAQ:TRUP) Posts Earnings Results, Beats Expectations By $0.09 EPS

Trupanion (NASDAQ:TRUP) announced its quarterly earnings data on Wednesday. The financial services provider reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09, Briefing.com reports. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The business had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same period in the previous year, the firm earned ($0.10) earnings per share. The firm’s quarterly revenue was up 14.6% compared to the same quarter last year. Trupanion updated its Q4 2024 guidance to EPS and its FY 2024 guidance to EPS.

Trupanion Trading Up 3.5 %

Shares of TRUP stock opened at $55.12 on Thursday. The company has a market cap of $2.32 billion, a P/E ratio of -86.13 and a beta of 1.73. Trupanion has a fifty-two week low of $19.14 and a fifty-two week high of $55.74. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. The stock has a 50 day simple moving average of $46.73 and a two-hundred day simple moving average of $35.87.

Insider Activity at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO Fawwad Qureshi sold 624 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Margaret Tooth sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares in the company, valued at approximately $4,647,256.32. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 8,764 shares of company stock worth $405,238 in the last quarter. Company insiders own 5.50% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Piper Sandler boosted their price objective on shares of Trupanion from $38.00 to $45.00 and gave the company a “neutral” rating in a report on Wednesday, October 2nd. Stifel Nicolaus raised their price objective on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research note on Monday, September 23rd. Northland Securities increased their target price on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a research note on Thursday, September 19th. Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research report on Friday, August 9th. Finally, Bank of America boosted their price objective on shares of Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Four equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Trupanion currently has an average rating of “Moderate Buy” and an average price target of $41.83.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.